1 : INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1. Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

2 : EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2.CXO perspective

3 : MARKET LANDSCAPE

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis
3.4.Market dynamics

3.4.1.Drivers

3.4.1.1.Increase in prevalence of chronic disease
3.4.1.2.Rise in geriatric populations
3.4.1.3.Significant benefits to the entire healthcare continuum
3.4.1.4.Increasing Prevalence of Chronic Diseases along with the Growing Geriatric Population

3.4.2. Restraints

3.4.2.1.High Cost of Services and Security Concerns

3.4.3.Opportunity

3.4.3.1.Novel Technological Advancements and Rising Healthcare Expenditure

3.4.4.Impact analysis

3.5.Impact analysis of COVID-19 on the Chronic Disease Management Market

CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Solution

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.2.4.Market size and forecast, by solution type

4.2.4.1.On-Premise Solution

4.2.4.1.1.Market size and forecast

4.2.4.2.Cloud-based Solutions

4.2.4.2.1.Market size and forecast

4.3.Services

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.3.4.Market size and forecast, by service type

4.3.4.1.Educational Service

4.3.4.1.1.Market size and forecast

4.3.4.2.Implementation Service

4.3.4.2.1.Market size and forecast

4.3.4.3.Consultant Service

4.3.4.3.1.Market size and forecast

5 : CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE

5.1.Overview

5.1.1.Market size and forecast

5.2.Cardiovascular diseases

5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country

5.3.Diabetes

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market analysis, by country

5.4.Cancer

5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market analysis, by country

5.5.Asthma

5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast, by region
5.5.3.Market analysis, by country

5.6.Chronic Obstructive Pulmonary Disorder

5.6.1.Key market trends, growth factors, and opportunities
5.6.2.Market size and forecast, by region
5.6.3.Market analysis, by country

5.7.Others

5.7.1.Key market trends, growth factors, and opportunities
5.7.2.Market size and forecast, by region
5.7.3.Market analysis, by country

6 : CHRONIC DISEASE MANAGEMENT MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast

6.2.Healthcare Providers

6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market analysis, by country

6.3.Healthcare Payers

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market analysis, by country

6.4.Others

6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by region
6.4.3.Market analysis, by country

7 : CHRONIC DISEASE MANAGEMENT MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.North America Chronic Disease Management Market, by Type
7.2.3.North America Chronic Disease Management Market, by Disease Type
7.2.4.North America Chronic Disease Management Market, by End user
7.2.5.Market size and forecast, by country

7.2.5.1.U.S.

7.2.5.1.1.U.S. Chronic Disease Management Market, by Type
7.2.5.1.2.U.S. Chronic Disease Management Market, by Disease Type
7.2.5.1.3.U.S. Chronic Disease Management Market, by End user

7.2.5.2.Canada

7.2.5.2.1.Canada Chronic Disease Management Market, by Type
7.2.5.2.2.Canada Chronic Disease Management Market, by Disease Type
7.2.5.2.3.Canada Chronic Disease Management Market, by End user

7.2.5.3.Mexico

7.2.5.3.1.Mexico Chronic Disease Management Market, by Type
7.2.5.3.2.Mexico Chronic Disease Management Market, by Disease Type
7.2.5.3.3.Mexico Chronic Disease Management Market, by End user

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Europe Chronic Disease Management Market, by Type
7.3.3.Europe Chronic Disease Management Market, by Disease Type
7.3.4.Europe Chronic Disease Management Market, by End user
7.3.5.Market size and forecast, by country

7.3.5.1.Germany

7.3.5.1.1.Germany Chronic Disease Management Market, by Type
7.3.5.1.2.Germany Chronic Disease Management Market, by Disease Type
7.3.5.1.3.Germany Chronic Disease Management Market, by End user

7.3.5.2.France

7.3.5.2.1.France Chronic Disease Management Market, by Type
7.3.5.2.2.France Chronic Disease Management Market, by Disease Type
7.3.5.2.3.France Chronic Disease Management Market, by End user

7.3.5.3.UK

7.3.5.3.1.UK Chronic Disease Management Market, by Type
7.3.5.3.2.UK Chronic Disease Management Market, by Disease Type
7.3.5.3.3.UK Chronic Disease Management Market, by End user

7.3.5.4.Italy

7.3.5.4.1.Italy Chronic Disease Management Market, by Type
7.3.5.4.2.Italy Chronic Disease Management Market, by Disease Type
7.3.5.4.3.Italy Chronic Disease Management Market, by End user

7.3.5.5.Spain

7.3.5.5.1.Spain Chronic Disease Management Market, by Type
7.3.5.5.2.Spain Chronic Disease Management Market, by Disease Type
7.3.5.5.3.Spain Chronic Disease Management Market, by End user

7.3.5.6.Rest of Europe

7.3.5.6.1.Rest of Europe Chronic Disease Management Market, by Type
7.3.5.6.2.Rest of Europe Chronic Disease Management Market, by Disease Type
7.3.5.6.3.Rest of Europe Chronic Disease Management Market, by End user

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Asia Pacific Chronic Disease Management Market, by Type
7.4.3.Asia Pacific Chronic Disease Management Market, by Disease Type
7.4.4.Asia Pacific Chronic Disease Management Market, by End user
7.4.5.Market size and forecast, by country

7.4.5.1.Japan

7.4.5.1.1.Japan Chronic Disease Management Market, by Type
7.4.5.1.2.Japan Chronic Disease Management Market, by Disease Type
7.4.5.1.3.Japan Chronic Disease Management Market, by End user

7.4.5.2.China

7.4.5.2.1.China Chronic Disease Management Market, by Type
7.4.5.2.2.China Chronic Disease Management Market, by Disease Type
7.4.5.2.3.China Chronic Disease Management Market, by End user

7.4.5.3.India

7.4.5.3.1.India Chronic Disease Management Market, by Type
7.4.5.3.2.India Chronic Disease Management Market, by Disease Type
7.4.5.3.3.India Chronic Disease Management Market, by End user

7.4.5.4.Australia

7.4.5.4.1.Australia Chronic Disease Management Market, by Type
7.4.5.4.2.Australia Chronic Disease Management Market, by Disease Type
7.4.5.4.3.Australia Chronic Disease Management Market, by End user

7.4.5.5.South-Korea

7.4.5.5.1.South-Korea Chronic Disease Management Market, by Type
7.4.5.5.2.South-Korea Chronic Disease Management Market, by Disease Type
7.4.5.5.3.South-Korea Chronic Disease Management Market, by End user

7.4.5.6.Rest of Asia-Pacific

7.4.5.6.1.Rest of Asia-Pacific Chronic Disease Management Market, by Type
7.4.5.6.2.Rest of Asia-Pacific Chronic Disease Management Market, by Disease Type
7.4.5.6.3.Rest of Asia-Pacific Chronic Disease Management Market, by End user

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.LAMEA Chronic Disease Management Market, by Type
7.5.3.LAMEA Chronic Disease Management Market, by Disease Type
7.5.4.LAMEA Chronic Disease Management Market, by End user
7.5.5.Market size and forecast, by country

7.5.5.1.Brazil

7.5.5.1.1.Brazil Chronic Disease Management Market, by Type
7.5.5.1.2.Brazil Chronic Disease Management Market, by Disease Type
7.5.5.1.3.Brazil Chronic Disease Management Market, by End user

7.5.5.2.Saudi Arabia

7.5.5.2.1.Saudi Arabia Chronic Disease Management Market, by Type
7.5.5.2.2.Saudi-Arabia Chronic Disease Management Market, by Disease Type
7.5.5.2.3.Saudi Arabia Chronic Disease Management Market, by End user

7.5.5.3.South-Africa

7.5.5.3.1.South-Africa Chronic Disease Management Market, by Type
7.5.5.3.2.South-Africa Chronic Disease Management Market, by Disease Type
7.5.5.3.3.South-Africa Chronic Disease Management Market, by End user

7.5.5.4.Rest of LEMEA

7.5.5.4.1.Rest of LEMEA Chronic Disease Management Market, by Type
7.5.5.4.2.Rest of LAMEA Chronic Disease Management Market, by Disease Type
7.5.5.4.3.Rest of LEMEA Chronic Disease Management Market, by End user

8 : COMPETITION LANDSCAPE

8.1.Product mapping
8.2.Competitive dashboard
8.3.Competitive heat map
8.4.Key developments
8.5.Top player positioning of top 10 players. 2021 10 Players

9 : COMPANY PROFILES

9.1. Hinduja Global Solutions Ltd

9.1.1.Company overview
9.1.2.Key Executive
9.1.3.Company snapshot
9.1.4.Operating business segments
9.1.5.Product portfolio
9.1.6.R&D expenditure.
9.1.7.Business performance

9.2. Koninklijke Philips N.V

9.2.1.Company overview
9.2.2.Key Executive
9.2.3.Company snapshot
9.2.4.Operating business segments
9.2.5.Product portfolio
9.2.6.Key strategic moves and developments

9.3. Cognizant TriZetto Software Group Inc

9.3.1.Company overview
9.3.2.Key Executive
9.3.3.Company snapshot
9.3.4.Operating business segments
9.3.5.Product portfolio

9.4. Vivify Health, Inc

9.4.1.Company overview
9.4.2.Key Executive
9.4.3.Company snapshot
9.4.4.Operating business segments
9.4.5.Product portfolio

9.5. cliexa, Inc .

9.5.1.Company overview
9.5.2.Key Executive
9.5.3.Company snapshot
9.5.4.Operating business segments
9.5.5.Product portfolio

9.6. Pegasystems Inc

9.6.1.Company overview
9.6.2.Key Executive
9.6.3.Company snapshot
9.6.4.Operating business segments
9.6.5.Product portfolio
9.6.6.Business performance

9.7. Cedar Gate Technologies

9.7.1.Company overview
9.7.2.Key Executive
9.7.3.Company snapshot
9.7.4.Operating business segments
9.7.5.Product portfolio

9.8. Altruista Health .

9.8.1.Company overview
9.8.2.Key Executive
9.8.3.Company snapshot
9.8.4.Operating business segments
9.8.5.Product portfolio
9.8.6.Business performance

9.9. Casenet, LLC .

9.9.1.Company overview
9.9.2.Key Executive
9.9.3.Company snapshot
9.9.4.Operating business segments
9.9.5.Product portfolio
9.9.6.R&D expenditure.
9.9.7.Business performance
9.9.8.Key strategic moves and developments

9.10. Infosys Ltd .

9.10.1.Company overview
9.10.2.Key Executive
9.10.3.Company snapshot
9.10.4.Operating business segments
9.10.5.Product portfolio

9.10.6.Business performance

9.11. Health Catalyst 
9.11.1.Company overview
9.11.2.Key Executive
9.11.3.Company snapshot
9.11.4.Operating business segments
9.11.5.Product portfolio
9.11.6.R&D expenditure.
9.11.7.Business performance

9.12. ExlServings Holdings, Inc .

9.12.1.Company overview
9.12.2.Key Executive
9.12.3.Company snapshot
9.12.4.Operating business segments
9.12.5.Product portfolio
9.12.6.R&D expenditure.
9.12.7.Business performance
9.12.8.Key strategic moves and developments

9.13. Medecision

9.13.1.Company overview
9.13.2.Key Executive
9.13.3.Company snapshot
9.13.4.Operating business segments
9.13.5.Product portfolio
9.13.6.Key strategic moves and developments

9.14. ZeOmega

9.14.1.Company overview
9.14.2.Key Executive
9.14.3.Company snapshot
9.14.4.Operating business segments
9.14.5.Product portfolio
9.14.6.R&D expenditure.
9.14.7.Business performance

9.15. Epic Systems Corporation .

9.15.1.Company overview
9.15.2.Key Executive
9.15.3.Company snapshot
9.15.4.Operating business segments
9.15.5.Product portfolio
9.15.6.R&D expenditure.
9.15.7.Business performance

9.16. Allscripts Healthcare, LLC

9.16.1.Company overview
9.16.2.Key Executive
9.16.3.Company snapshot
9.16.4.Operating business segments
9.16.5.Product portfolio

9.17. NXGN Management, LLC

9.17.1.Company overview
9.17.2.Key Executive
9.17.3.Company snapshot
9.17.4.Operating business segments
9.17.5.Product portfolio
9.17.6.Key strategic moves and developments